glp-1 reactive hypoglycemia GLP-1: Actions on Beta-cell Mass and Function Glucagon-like Peptide-1: Actions and Influence

Objective The objective of this narrative review is to examine the physiological and clinical evidence regarding the potential role of testosterone replacement therapy in preserving lean mass among men with persistently low serum testosterone levels undergoing GLP-1 receptor agonist-associated weight loss

After propensity score matching, there was no significant difference found for the risk of oral steroid use (aOR: 0.81, 95% CI: 0.481.36), intravenous steroid use (aOR: 0.69, 95% CI: 0.291.61), the need to initiate advanced therapy (aOR: 1.03, 95% CI: 0.412.60), or the risk of any-cause emergency department visits (aOR: 0.92 (0.521.61) at one year between the semaglutide-treated and non-semaglutide-treated IBD patients

Fermentation patterns of prebiotics fructooligosaccharides-SCFA esters inoculated with fecal microbiota from ulcerative colitis patients

Expect pharmaceutical-equivalent results

Genetic Factors That Influence How You Respond to Green Tea and GLP-1 Individual differences in how your body processes catechins and responds to GLP-1 medications are partly determined by genetic variation